| Drug Class | Generic/Trade/ Company Names | Indication | Approving Regulatory Agency |
HIV and AIDS | Abacavir Sulfate
Ziagen
Glaxo Wellcome | - A nucleoside analogue reverse transcriptase inhibitor for the treatment of HIV and AIDS
| HPB – Ottawa |
Male Pattern Hair Loss | Minoxidil 2% Topical Solution
Taisho | | Japanese Pharmaceutical and Medical Safety Bureau |
Finasteride
Propecia
1mg Tablets Merck Sharp & Dohme | - An additional indication of male-pattern hair loss
| UK MCA |
Oncologic
Agents | Aldesleukin
Proleukin
Chiron | - An additional indication for treatment of malignant metastatic melanoma
| HPB – Ottawa |
Alitretinoin
Panretin
Gel 0.1% Ligand Pharmaceutical | - For topical treatment of cutaneous lesions in patients with AIDS related Kaposi’s Sarcoma
| US FDA
HPB – Ottawa |
Allovectin-7
Vical | - For treatment of invasive and metastatic melanoma
| US FDA
(orphan drug status) |
Bexarotene
Targretin
75mg Capsules Ligand Pharmaceuticals | - For treatment of cutaneous manifestations of cutaneous T-cell lymphoma (CTCL) in patients who are refractory to one or more prior systemic treatments for CTCL
| US FDA |
Denileukin Diftitox
Ontak
Ligand Pharmaceuticals | - For the treatment of CTCL
| US FDA
(accelerated approval) |
G-3139
Vical | - For the treatment of advanced malignant melanoma
| US FDA
(fast-track designation) |
Interferon Alpha-2a
Roferon-A
Hoffmann-La Roche | - For the adjuvant treatment of malignant melanoma patients who are at risk for relapse following resection
| European Commission
(CPMP) |
Melanoma Lysate
Melacine Therapeutic Vaccine
Schering-Plough | - For the treatment of late stage (IV) melanoma
| HPB – Ottawa |
Methoxsalen
Uvadex
Therakos | - For palliative treatment of the skin manifestations of CTCL that are unresponsive to other forms of therapy
| US FDA |
Osteoporosis | Alendronate
Fosamax
Merck | - For treatment of glucocorticoid induced osteoporosis in patients receiving glucocorticoids in a daily dosage equivalent to ≥ 7.5mg prednisone and who have low bone mineral density
| US FDA |
Pediculocides | Malathion
Ovide 0.5% Lotion
Medicis Pharmaceutical | - For treatment of head lice and their ova
| For treatment of head lice and their ova US FDA |
Pyrethrins/Piperonyl
Butoxide
Rid Aerosol Foam Mousse
Pfizer | - For treatment of head lice
| US FDA |
Photodynamic
Therapy | Aminolevulinic Acid
Levulan
Photodynamic Therapy DUSA Pharmaceuticals | - For treatment of actinic keratoses of the face and
scalp
| US FDA |
Topical
Anesthetics | Lidocaine 5%
Lidoderm
Patch Endo Pharmaceuticals | - For treatment of postherpetic neuralgia
| US FDA |
Lidocaine/Prilocaine
EMLA
Cream
Astra | - An additional indication for use in pediatric patients
| US FDA |
Vaginal Atrophy | Estradiol
Estradiol Transdermal System
Wyeth Ayerst Laboratories | - For the treatment of vulvar and vaginal atrophy
| US FDA |
